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Summary
Background Malaria is endemic in 13 of 64 districts in Bangladesh. About 14 million people are at risk. Some evidence 
suggests that the prevalence of malaria in Bangladesh has decreased since the the Global Fund to Fight AIDS, 
Tuberculosis and Malaria started to support the National Malaria Control Program (NMCP) in 2007. We did an 
epidemiological and economic assessment of malaria control in Bangladesh.
Methods We obtained annually reported, district-level aggregated malaria case data and information about disbursed 
funds from the NMCP. We used a Poisson regression model to examine the associations between total malaria, 
severe malaria, malaria-attributable mortality, and insecticide-treated net coverage. We identifi ed and mapped malaria 
hotspots using the Getis-Ord Gi* statistic. We estimated the cost-eff ectiveness of the NMCP by estimating the cost per 
confi rmed case, cost per treated case, and cost per person of insecticide-treated net coverage.
Findings During the study period (from Jan 1, 2008, to Dec 31, 2012) there were 285 731 confi rmed malaria cases. 
Malaria decreased from 6·2 cases per 1000 population in 2008, to 2·1 cases per 1000 population in 2012. Prevalence 
of all malaria decreased by 65% (95% CI 65–66), severe malaria decreased by 79% (78–80), and malaria-associated 
mortality decreased by 91% (83–95). By 2012, there was one insecticide-treated net for every 2·6 individuals 
(SD 0·20). Districts with more than 0·5 insecticide-treated nets per person had a decrease in prevalence of 21% 
(95% CI 19–23) for all malaria, 25% (17–32) for severe malaria, and 76% (35–91) for malaria-associated mortality 
among all age groups. Malaria hotspots remained in the highly endemic districts in the Chittagong Hill Tracts. The 
cost per diagnosed case was US$0·39 (SD 0·02) and per treated case was $0·51 (0·27); $0·05 (0·04) was invested 
per person per year for health education and $0·68 (0·30) was spent per person per year for insecticide-treated net 
coverage.
Interpretation Malaria elimination is an achievable prospect in Bangladesh and failure to push for elimination nearly 
ensures a resurgence of disease. Consistent fi nancing is needed to avoid resurgence and maintain elimination goals.
Funding None. 
Introduction
Bangladesh has a history of endemic malaria transmission 
in 13 of 64 districts. Up to 70 000 laboratory-confi rmed and 
900 000 clinical cases (appendix p 1), with more than 
500 deaths per year, were reported in the late 1990s.1–3 
Unreported cases might have been as high as 250 000 each 
year.4 A cross-sectional survey in 2007 reported a crude 
prevalence of 4% in the 13 malaria-endemic districts.5 
More than 90% of cases were Plasmodium falciparum.5 The 
highest prevalence (>10%) was identifi ed in three districts 
of the Chittagong Hill Tracts in southeastern Bangladesh.5
The Global Fund to fi ght AIDS, Tuberculosis and 
Malaria (Global Fund) approved funds in 20064 (Round 6) 
and 20096 (Round 9) to support the Bangladesh National 
Malaria Control Program (NMCP). The NMCP was 
implemented by the Bangladesh Ministry of Health with 
BRAC (a national non-governmental development 
organisation). The goals were to: (1) reduce malaria 
morbidity and mortality; (2) provide community-based 
services that increased access to diagnosis and treatment 
with artemisinin-based combination therapies in hard-to-
reach regions; (3) provide longlasting insecticidal nets 
(LLINs) to 100% of households in the three malaria-
endemic districts with the highest malaria burden and 
80% coverage in the other ten malaria-endemic districts; 
(4) strengthen the malaria epidemiological surveillance 
system; (5) strengthen partnerships in malaria control; 
and (6) provide periodic (every 3 years) treatment of 
non-LLIN with suitable insecticides.4,6
These interventions started in late 2007, and were fully 
implemented in the 13 malaria-endemic districts in 
2008. There has been a general reduction in malaria 
cases, presumably through high coverage of and 
increased use of insecticide-treated nets, increased use 
of rapid diagnostic tests and antimalarial treatments, 
and a high number of community health workers and 
health facilities.7–9 The interventions have also reached 
marginalised populations.8 Bangladesh is moving from 
control to elimination in parts of the country, but 
evidence in favour of these actions has been more 
descriptive than quantitative so a robust cost–benefi t 
analysis is crucial. Cost-eff ectiveness analysis is needed 
to maintain sustainable control programmes and assess 
the future needs for malaria elimination.
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Malaria elimination also has substantial indirect 
benefi ts and economic attractiveness.10,11 A systematic 
assessment of the eff ect of the programme has not been 
done in Bangladesh. Both donors and policy makers 
should have information about the costs and benefi ts of 
interventions. To address this gap, we did an 
epidemiological and economic analysis using the 
country’s number of malaria episodes, total costs of the 
programme, and disbursed funds from 2008 to 2012 in 
the 13 malaria-endemic districts. We compared 
international donor assistance to control malaria in 
Bangladesh with other malaria-endemic countries.
Methods
Study area
The population of Bangladesh is about 150 million; 
14 million people live in the 13 malaria-endemic 
districts.12 Eight of these districts are in the north of 
Bangladesh, sharing a border with India, and fi ve 
districts are in southeast Bangladesh, sharing borders 
with India and Myanmar (Burma).
Data sources
The main methods of malaria surveillance in Bangladesh 
are passive case detection at hospitals and rapid diagnosis 
and treatment at the community level by community 
health workers. We obtained annually reported, district-
level aggregated malaria case data from the NMCP. 
Uncomplicated malaria, severe malaria (defi ned by clinical 
and laboratory variables associated with an increased risk 
of death and the presence of P falciparum parasitaemia)13,14 
involving admission to hospital, and malaria-associated 
mortality, were confi rmed by microscopy or rapid 
diagnostic tests done in hospitals or by community health 
workers. Appendix p 2 shows the malaria reporting system 
in Bangladesh in more detail. We obtained data for the 
number of LLINs distributed and nets treated (new 
available non-LLIN) with K-O-tab 12315 (together designated 
as insecticide-treated nets) annually from the NMCP. 
LLINs were costed at $6·00 per net, and insecticide 
treatment of nets at $0·50 per net. We took demographic 
data from the Bangladesh Bureau of Statistics.16 
Populations were projected for 2008, 2009, 2010, and 
2012 using an exponential population growth model based 
on Bangladesh Bureau of Statistics 2001 and 2011 data.16
We obtained detailed data from the Bangladesh NMCP 
for funds disbursed to the NMCP from the donors (Global 
Fund, Bangladesh Government). Once the investments 
from the Global Fund arrived in Bangladesh, they were 
deposited in the Ministry of Health according to the US 
dollar rate. Infl ation rates were calculated on the basis of 
diff erences between the rate at the time the funds were 
received and the reporting time at the end of the fi scal year. 
We obtained cost data in US dollars from the Bangladesh 
NMCP manager. All costs were cross-checked with budgets 
outlined in the original proposals submitted to the Global 
Fund and through reviews of available reports.
Data analysis
We analysed yearly aggregated district-level age 
(0·0–4·0 years, 4·1–14·0 years, and >14·0 years) and sex-
specifi c malaria data for all 13 malaria-endemic districts. 
We used detailed demographic data from the Bangladesh 
Bureau of Statistics as the denominator. We calculated 
the prevalence17 of any malaria, severe malaria, and 
malaria-associated mortality per 1000 population. For all 
13 districts, we calculated coverage of insecticide-treated 
nets per 1000 population, assuming an average net life of 
3 years.18 We used Poisson regression to explore the 
association between malaria prevalence and insecticide-
treated net coverage at the district level. We used STATA 
(version 11) for all statistical analyses.
Yearly malaria data (total number of malaria episodes, 
P falciparum, Plasmodium vivax, and mixed infections) 
were linked with district shape fi les (geographic data). 
District-level malaria prevalence in each year and the 
percentage of P falciparum, P vivax, and mixed infections 
were mapped separately and analysed for spatial 
clustering using the Getis-Ord Gi* statistic19 in ArcGIS 
software (version 10). This statistic established whether 
diff erences between the local mean (ie, the prevalence for 
a district and its nearest neighbouring districts) was 
signifi cantly diff erent from the global mean (ie, the 
prevalence for all districts).20 A signifi cant positive 
Z score identifi ed a hotspot for high prevalence and a 
signifi cant negative Z score for a district identifi ed local 
clustering of low prevalence.21–23
For the economic analyses, all costs were treated as 
capital costs (eg, transportation, human resources, 
training, infrastructures, institutional overhead, 
operational research), except costs for drugs, diagnoses, 
health education (information education communication 
or behaviour change communication), LLINs, and 
impregnation of nets to prevent malaria, which were 
treated as operating costs. The population (14 million Figure 1: Prevalence of total malaria, severe malaria, and malaria mortality in Bangladesh (2008–12)
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people) living in malaria-endemic districts of the country 
was used as the denominator.
For the analysis of international donor assistance to 
control malaria, we calculated each malaria-endemic 
country’s total expenditures from international donors to 
control malaria from 2008 to 2012, and their populations 
living in malaria-endemic regions. We compared the 
total population living at risk and disbursed funds for 
malaria control in Bangladesh with other malaria-
endemic countries.
Role of the funding source
There was no funding source for this study. The 
corresponding author had full access to all the data in the 
study and had fi nal responsibility for the decision to 
submit for publication.
Results
During the study period (from Jan 1, 2008, to Dec 31, 2012) 
there were 285 731 confi rmed malaria cases in the 
13 malaria-endemic districts. There was a steep decrease in 
malaria from 6·2 cases per 1000 population in 2008, to 
2·1 cases per 1000 population in 2012 (fi gure 1). Between 
2008 and 2012, prevalence of all malaria decreased by 65% 
(95% CI 65–66), severe malaria decreased by 79% (78–80), 
and malaria-associated mortality decreased by 91% (83–95) 
(table). Malaria prevalence among male individuals was 
1·3 times higher than in female individuals over the course 
of the study (table). Malaria prevalence decreased between 
2008 and 2012 in all age groups (table), but the highest 
decrease was in children aged 0–4 years: 77% (95% CI 
76–78; appendix p 3).
From 2008 to 2012, the Bangladesh NMCP did 
2·2 million diagnostic tests for malaria (71% microscopy, 
29% rapid diagnostic tests). Of 285 731 tests that were 
positive for malaria, 56% (160 715) were confi rmed by 
rapid diagnostic test (Paracheck-Pf, Orchid, Biomedical 
System, Verna, Goa, India)24 and 44% (125 863) were 
confi rmed by microscopy (appendix p 4). Treatments 
provided by the Bangladesh NMCP for patients with 
malaria were artemether-lumefantrine, chloroquine, 
primaquine, and quinine (appendix pp 9–11).
Most malaria cases were P falciparum (89·3%, 255 266), 
10·3% (29 367) were P vivax, and 0·4% (1089) were mixed 
infections (P falciparum plus P vivax; appendix pp 5–7). 
During the study period, 3·11 million new LLINs were 
supplied and an additional 3·77 million nets were treated 
with insecticide.15 By 2012, there was one insecticide-
treated net for every 2·6 individuals (SD 0·20) in the 
13 malaria-endemic districts (fi gure 2).
The decrease in malaria prevalence in all age groups 
was associated with increased insecticide-treated net 
coverage (table). Districts with more than 0·5 insecticide-
treated nets per person had an annual decrease in 
prevalence of 21% for all malaria, 25% for severe malaria, 
and 76% for malaria-associated mortality among all age 
groups (table). Coverage of more than 0·5 insecticide-
treated nets per person was associated with a greater 
Any malaria Severe malaria Malaria-associated 
mortality
0·0–4·0 years 4·1–14·0 years >14·0 years Male Female
Year
2008 1 1 1 1 1 1 1 1
2009 0·74 (0·74–0·75) 1·13 (1·08–1·17) 0·34 (0·23–0·48) 0·54 (0·52–0·55) 0·69 (0·68–0·71) 0·83 (0·82–0·84) 0·77 (0·76–0·78) 0·72 (0·71–0·73)
2010 0·65 (0·65–0·66) 0·89 (0·85–0·94) 0·34 (0·22–0·54) 0·50 (0·49–0·52) 0·63 (0·62–0·65) 0·72 (0·71–0·73) 0·70 (0·69–0·71) 0·61 (0·60–0·62)
2011 0·62 (0·62–0·63) 0·53 (0·51–0·56) 0·34 (0·21–0·54) 0·47 (0·46–0·49) 0·64 (0·63–0·66) 0·66 (0·65–0·67) 0·69 (0·68–0·70) 0·56 (0·55–0·57)
2012 0·35 (0·34–0·35) 0·21 (0·20–0·22) 0·09 (0·05–0·17) 0·23 (0·22–0·24) 0·32 (0·31–0·33) 0·40 (0·40–0·41) 0·39 (0·38–0·40) 0·30 (0·30–0·31)
ITN coverage (number of nets per person)*
0·00–0·10 1 1 1 1 1 1 1 1
0·11–0·30 0·97 (0·95–0·99) 1·17 (1·09–1·26) 0·39 (0·18–0·85) 0·84 (0·77–0·91) 0·84 (0·80–0·88) 0·99 (0·96–1·02) 0·94 (0·91–0·96) 0·99 (0·96–1·03)
0·31–0·50 0·78 (0·76–0·79) 0·92 (0·84–0·99) 0·31 (0·14–0·68) 0·49 (0·45–0·53) 0·53 (0·50–0·56) 0·86 (0·83–0·88) 0·82 (0·80–0·84) 0·68 (0·65–0·70)
>0·50 0·79 (0·77–0·81) 0·75 (0·68–0·83) 0·24 (0·09–0·65) 0·48 (0·43–0·53) 0·49 (0·46–0·52) 0·93 (0·91–0·96) 0·83 (0·81–0·86) 0·68 (0·66–0·71)
ITN=insecticide-treated net. *Average coverage for 2008–12.
Table: Malaria prevalence rate ratio (95% CI) in Bangladesh according to year and coverage of ITN
Figure 2: Mean number of insecticide-treated nets per person in the 13 malaria-endemic districts of 
Bangladesh, 2008–12
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annual decrease in malaria prevalence in female 
individuals (prevalence rate ratio 0·68; 95% CI 
0·66–0·71) than in male individuals (0·83; 0·81–0·86; 
table).
Three districts in the Chittagong Hill Tracts and four 
districts in northeastern Bangladesh (Sylhet, 
Moulvibazar, Hobigong, and Netrokona) reported 
continuous malaria hotspots for P falciparum from 
2008 to 2012; the number of cases of P vivax and mixed 
infections fl uctuated in all endemic districts 
(appendix pp 5–7). There was a continuous reduction of 
malaria cases in all endemic districts in the northeast 
and in the Chittagong and Rangamati districts in 
southeast Bangladesh until 2011 (fi gure 3). In 2012, the 
number of malaria cases was reduced compared with 
2008 in all fi ve districts in the south; Kurigram and 
Mymensingh in the north; and Hobigong and 
Moulvibazar in the northeast of Bangladesh (fi gure 3).
Bangladesh spent US$39·81 million (89% from the 
Global Fund and 11% from the Bangladesh Government) 
to control malaria from 2008 to 2012. The yearly average 
investment per person to control malaria was $0·41 from 
2008 to 2012.
Assuming one insecticide-treated net provides cover for 
two individuals, the amount spent for distribution of 
6·88 million insecticide-treated nets (LLINs and non-
LLINs) was $0·68 (SD 0·30) per person per year during 
2008–12. During the study period, the mean cost per 
diagnosed malaria case was $0·39 (SD 0·02) and the 
average cost per malaria case treated was $0·51 (0·27). 
Bangladesh also spent an average of $0·05 (0·04) per 
person yearly for health education.
Figure 3: Malaria prevalence in Bangladesh in 2008, and progress in malaria control from 2009 to 2012
For 2009–2012, red areas show the regions with the largest decreases in malaria prevalence.
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From 2008 to 2012, 87 malaria-endemic countries 
received fi nancial support from international donors to 
control malaria.25,26 In terms of size of population living at 
risk of malaria, of 91 endemic countries, Bangladesh 
(14 million people living in endemic districts) ranked 
29th.25,26 However, Bangladesh ranked 57th in terms of 
amount of international funding invested ($2·04 per 
person; fi gure 4).25,26
Discussion
The prevalence of all malaria, severe malaria, and 
malaria-associated mortality decreased in Bangladesh 
after 5 years of interventions. The annual number of 
cases declined, especially in children aged 0–4 years. 
Bangladesh achieved high insecticide-treated net 
coverage and the extent of coverage was associated with 
the reduction in cases. Cost per diagnosis,27,28 cost per 
Figure 4: Mean population living at risk of malaria (2008–12) and spend per person on malaria control from international donor funds (2008–12)
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treated case,27 and cost of insecticide-treated net 
coverage27,29–32 were lower than for malaria control 
programmes in other countries, suggesting that the 
Bangladesh NMCP is cost-eff ective. 
Despite limited funds, the Bangladesh NMCP has 
achieved success in reducing malaria.27,33,34 Increased 
prevention and control measures have reduced the 
malaria burden in Bangladesh, although some of the 
decreases might have been a result of external factors.
Bangladesh provided one insecticide-treated net for 
every 2·6 individuals in the 13 malaria-endemic 
districts, higher than many other malaria-endemic 
countries.35–37 Results of another study in the Bandarban 
district showed that more than 90% of individuals slept 
under nets during the night before the interview.38 Of 
the nets used, about 80% were reported to be insecticide-
treated and more than 95% of children younger than 
5 years used an insecticide-treated net.38 Since increased 
insecticide-treated net coverage was associated with a 
reduction in malaria cases in the present study, 
maintenance of high coverage of insecticide-treated 
nets will probably be crucial in future.
For diagnosis of malaria, the proportional use of 
rapid diagnostic tests (29%) was much lower than that 
of microscopy (71%; appendix p 8). However, the 
proportion of confi rmed cases diagnosed by rapid 
diagnostic tests was higher (56%) than for microscopy 
(44%). This fi nding might have arisen because 
microscopy is mainly used in government hospitals to 
which most people refer for treatment but which are 
mainly located in urban areas where malaria-infection 
rates are low. Rapid diagnostic tests are mainly used by 
community health workers working in hard-to-reach 
regions in which prevalence is thought to be higher.
The lower prevalence of malaria in female individuals 
than male individuals might relate to the high risk of 
exposure in typically male occupations, such as 
agricultural and forestry.4,39 Behavioural diff erences 
might also play a part; for example, women are generally 
well covered with clothing, prefer to sleep earlier 
(therefore spending more time under nets), and tend to 
sleep with their children under nets.4,38,39
After 5 years of malaria control interventions, 
hotspots persist in the Chittagong Hill Tracts. More 
intensive and targeted surveillance systems, including 
mapping of asymptomatic carriers, is needed.7 
Identifi cation and targeting of transmission in the 
Chittagong Hill Tracts and Cox’s Bazar district on a 
regular basis will be crucial to reduce the malaria 
burden.5,8,12,40,41
Currently, Bangladesh has elimination programmes 
(begun in 2012) in four districts in northeast 
Bangladesh. The programmes monitor annual malaria 
cases at the district level. Monthly malaria maps at the 
lowest administrative level (mauza) could further help 
control programmes to be more cost-eff ective by more 
accurately targeting resources.
The costs per person for diagnosis ($0·39) and 
treatment ($0·51) of malaria in Bangladesh were low 
compared with other countries (range $0·88–9·54).27,28,42 
Bangladesh also spent a small amount of funds on 
health education with a radio, leafl et, and advertisement 
campaign. So far, artemisinin-based combination 
therapies (lumefantrine-artemether, artesunate; appendix 
pp 9–11) are highly eff ective for treatment of malaria in 
Bangladesh.43,44 However, close monitoring of drug 
resistance is essential in Bangladesh because resistance 
to artemisinin-based combination therapies has been 
reported at the Thai–Cambodia border45 and more 
recently at the Thai–Myanmar border.46 Monitoring of 
the potential spread of resistance of artemisinin-based 
combination therapies should be a high priority in 
Bangladesh.
In addition to providing relatively expensive LLINs, the 
NMCP also supported cheaper insecticide treatment of 
nets,15 thus Bangladesh maintained highly cost-eff ective 
insecticide-treated net coverage compared with other 
malaria-endemic countries.29–32
The average international donor support for malaria 
control worldwide to malaria-endemic countries was 
US$1·86 per person per year.47 The corresponding 
fi gure for Bangladesh was $0·41  per person per year 
for the population living at risk of malaria, which is less 
than the $0·70 per person per year given to the 
countries in the southeast Asian and western Pacifi c 
regions.47
The greatest threat to a successful elimination plan for 
Bangladesh is the border areas with Myanmar and 
Indian states of Assam, Tripura, Meghalaya, and 
Mizoram.48–54 Areas adjacent the porous border are 
malaria endemic, largely mountainous, and composed of 
forest reserves. A cross-border malaria strategy with 
India and Myanmar is crucial to maintain the gains that 
have been achieved. One way could be to implement 
border screening and develop cross-border and regional 
malaria collaborations that will move Bangladesh 
forward in malaria elimination.
This study has a number of limitations. For example, it 
is known that economic development and urbanisation 
can be associated with reduced malaria.55 It is, therefore, 
possible that not all improvements in the malaria 
situation were attributable to the control activities of the 
NMCP. Bangladesh has undergone substantial progress 
in terms of general societal development. This progress 
and improved access to health care in general could have 
contributed to a decrease in malaria prevalence 
irrespective of the activities of the NMCP. The number of 
malaria cases identifi ed for the present study might be 
underestimated if substantial numbers of people acquire 
antimalarial drugs from vendors that do not report to the 
country’s malaria record. The rapid diagnostic test used 
by the Bangladesh NMCP (Paracheck-Pf) only detects 
P falciparum, leaving P vivax infections (which can be 
detected by microscopy) undetected. False positives or 
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negatives with either microscopy or rapid diagnostic tests 
were not considered. Importation risk from India or 
Myanmar has not been considered and the cost 
calculations also did not take into account expired 
antimalarial drugs and rapid diagnostic tests or loss in 
the government stocks.
Malaria control in Bangladesh is mostly donor-
dependent. The country has been successful in securing 
$39·81 million from the Global Fund for its malaria 
programme from 2008 to 2012 and obtained a further 
$25 million until June, 2015, from the Global Fund. 
However, the Bangladesh NMCP is currently 
underfunded relative to the size of the population living 
at risk of malaria, and improved funding will be crucial 
for elimination eff orts. The present assessment will 
support future malaria control strategies by the Ministry 
of Health in Bangladesh and donors. A resurgence of 
malaria in Bangladesh is nearly assured if control and 
surveillance measures are scaled back before elimination 
has been achieved (panel).56,57 Consistent fi nancing, 
which will require a substantial change in the approach 
to malaria funding, is necessary to avoid resurgence. The 
case for elimination is already suffi  ciently compelling for 
Bangladesh. The benefi ts are not only local, but also 
international if Bangladesh can act as a buff er against the 
spread of artemisinin resistance from the Mekong region 
to the Indian subcontinent. Furthermore, experiences 
from the fi eld in countries involved in malaria control, 
such as Bangladesh, will also be of importance for 
programme design in other malaria-endemic countries.
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